Thiazolidinedione (TZD) encompasses a class of drugs that activate peroxisome proliferator activated receptor gamma (PPARγ), which is a key transcription factor that induces insulin-sensitive genes and is targeted in Type II diabetes mellitus treatment [12,13]. Here, PPARG is linked to type 2 diabetes mellitus.